Dolby Laboratories (DLB) reported $357 million in revenue for the quarter ended December 2024, representing a year-over-year increase of 13.1%. EPS of $1.14 for the same period compares to $1.01 a year ago.The reported revenue compares to the Zacks Consensus Estimate of $346.37 million, representing a surprise of +3.07%. The company delivered an EPS surprise of +6.54%, with the consensus EPS estimate being $1.07.While investors closely watch year-over-year changes in headline numbers -- revenue and earnings ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Quarterly Period Ended December 27, 2024 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Transition Period From To Commission File Number: 001-32431 DOLBY LABORATORIES, INC. (Exact name of registrant as specified in its charter) Delaware 90-0199783 (State or o ...

Dolby Laboratories, Inc (DLB) reported first-quarter fiscal 2025 results, with non-GAAP earnings per share (EPS) of $1.14 compared with $1.01 reported in the prior-year quarter. The bottom line surpassed the Zacks Consensus Estimate by 6.5%. Strong revenues and higher gross margins were primary growth drivers.Stay up-to-date with all quarterly releases: See Zacks Earnings Calendar.Total revenues were $357 million, up from $315.6 million in the year-ago quarter and beat the Zacks Consensus Estimate by 3.1%. ...

– Study demonstrated strong therapeutic responses across behavioral, functional, cognitive, and movement measures in patients with mild-to-moderate DLB – – Zervimesine-treated participants tested 86% better on behavioral outcomes (NPI A-L), 52% on activities of daily living, 91% on cognitive fluctuations, 62% on motor symptoms compared to placebo – PURCHASE, N.Y., Jan. 30, 2025 (GLOBE NEWSWIRE) -- Cognition Therapeutics, Inc., (the Company or Cognition) (NASDAQ: CGTX), a clinical stage company developing dr ...

Dolby Laboratories (DLB) came out with quarterly earnings of $1.14 per share, beating the Zacks Consensus Estimate of $1.07 per share. This compares to earnings of $1.01 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of 6.54%. A quarter ago, it was expected that this creator and licensor of audio, video and voice technologies would post earnings of $0.68 per share when it actually produced earnings of $0.81, delivering a surpris ...

Exhibit 99.1 Dolby Laboratories Reports First Quarter 2025 Financial Results SAN FRANCISCO, January 29, 2025 — Dolby Laboratories, Inc. (NYSE:DLB) today announced the company's financial results for the first quarter of fiscal 2025. • At CES, our partners announced a wide range of new products incorporating Dolby technologies, including: • Soundbar announcements from Harmon Kardon, Samsung, and Amazon all support Dolby technology. • TV launches from partners including Hisense, TCL, Panasonic, Sharp, and RCA ...

SAN FRANCISCO, Jan. 29, 2025 /PRNewswire/ -- Dolby Laboratories, Inc. (NYSE:DLB) today announced the company's financial results for the first quarter of fiscal 2025."We are off to a strong start for FY25," said Kevin Yeaman, President and CEO, Dolby Laboratories. "In Q1, Dolby Atmos and Dolby Vision momentum continued across device categories. At CES, many of our device partners announced a wide range of Dolby enabled products, and customers experienced the first Dolby Vision enabled car with Li Auto."Firs ...

Dolby Laboratories Inc (DLB) is slated to report first-quarter fiscal 2025 results on Jan. 29.Stay up-to-date with all quarterly releases: See Zacks Earnings Calendar.The Zacks Consensus Estimate for fiscal first-quarter revenues is pegged at $346.4 million, which implies growth of 9.8% from the year-ago quarter’s reported figure. DLB expects revenues of $330-$360 million.For the first quarter of fiscal 2025, Dolby expects non-GAAP EPS between 96 cents and $1.11. The consensus mark for earnings is pegged at ...

The market expects Dolby Laboratories (DLB) to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended December 2024. This widely-known consensus outlook is important in assessing the company's earnings picture, but a powerful factor that might influence its near-term stock price is how the actual results compare to these estimates.The stock might move higher if these key numbers top expectations in the upcoming earnings report, which is expected to be ...

For new and old investors, taking full advantage of the stock market and investing with confidence are common goals. Zacks Premium provides lots of different ways to do both.Featuring daily updates of the Zacks Rank and Zacks Industry Rank, full access to the Zacks #1 Rank List, Equity Research reports, and Premium stock screens, the research service can help you become a smarter, more self-assured investor.It also includes access to the Zacks Style Scores. What are the Zacks Style Scores? Developed alongsi ...